Healthcare


 Unfolding the latest Developments in 3 Health Care Stocks- OVN, SPL and MSB

Unfolding the latest Developments in 3 Health Care Stocks- OVN, SPL and MSB

September 05, 2019 01:05 PM AEST| By Team Kalkine Media

One of the best in the world, Australian health care sector is unceasingly advancing technologies to deliver the best health care services. Despite, a few uncertainties, health care sector caught investors? attention to invest in leading biotechnolog...

 Oro-Mucosal Drug Delivery Leader, SUDA Pharmaceuticals Releases Preliminary Final Report

Oro-Mucosal Drug Delivery Leader, SUDA Pharmaceuticals Releases Preliminary Final Report

September 04, 2019 09:24 PM AEST| By Team Kalkine Media

Drugs intake in the form of pills, capsules, and tablets are not the most efficient ways of taking medicine, because only about 25% of the drug reaches where it should. Several factors including food affect, enzymatic degradation, drug metabolism, an...

 Immuno-Oncology Market Player, Imugene Delivers Remarkable Performance In FY 2019

Immuno-Oncology Market Player, Imugene Delivers Remarkable Performance In FY 2019

September 03, 2019 05:56 PM AEST| By Team Kalkine Media

Clinical stage immuno-oncology firm headquartered in Australia, Imugene Limited (ASX: IMU) is engaged in the development of a wide range of new treatments that attempt to activate the cancer patients? immune system to detect and remove tumours. Imuge...

 Can Healthcare stocks make your life better?

Can Healthcare stocks make your life better?

September 03, 2019 03:05 PM AEST| By Team Kalkine Media

Amidst global trade worries and lower bond returns, investors are flocking to equity market. One such sector gaining interests of market players is Healthcare sector comprising. The sector represents ample lucrative stocks with strong growth prospect...

 Noxopharm Unveils Further Promising Results: Veyonda® Enhances Radiotherapy in Prostate Cancer Treatment

Noxopharm Unveils Further Promising Results: Veyonda® Enhances Radiotherapy in Prostate Cancer Treatment

September 03, 2019 01:32 PM AEST| By Team Kalkine Media

Noxopharm Limited (ASX: NOX) is an Australian clinical-stage drug development company, which recently marked its third anniversary on the Australian Securities Exchange since its listing in August 2016. The company is primarily focused on the develop...

 Latest With Healthcare Players In Penny Space - EX1, OVN, BD1, OSL

Latest With Healthcare Players In Penny Space - EX1, OVN, BD1, OSL

August 31, 2019 08:15 AM AEST| By Team Kalkine Media

The science of Regenerative Medicine is a rapidly emerging field linking the medical technology, biotechnology and pharmaceutical sectors, and holds much potential to deliver better patient outcomes and drive economic growth.? Regenerative Medicine T...

 2 Most Important Things To Consider When Looking At Health Care Stocks – RHC, BIT, PAR

2 Most Important Things To Consider When Looking At Health Care Stocks – RHC, BIT, PAR

August 30, 2019 11:57 PM AEST| By Team Kalkine Media

Australia has a robust health care system, jointly operated by the federal, state and local governments, and is labeled as one of the best in the world. For investors, health care stands among the top few sectors, and is the safest sectors in Austral...

 An Eye On Latest Updates On Three Health Care Stocks: SPL, TLX, PBP

An Eye On Latest Updates On Three Health Care Stocks: SPL, TLX, PBP

August 30, 2019 02:45 PM AEST| By Team Kalkine Media

The benchmark Index S&P/ASX 200 settled at 6,604.2 on 30 August 2019, up 96.8 points or 1.47% from its previous close, while S&P/ASX 200 Health Care (Sector) inched up 674 points or 1.83% to settle at 36,822.2. Below discussed are three compa...

 Why should you consider investing in Cortical Dynamics? Cortical Dynamics’ Funding Offer

Why should you consider investing in Cortical Dynamics? Cortical Dynamics’ Funding Offer

August 30, 2019 02:22 PM AEST| By Team Kalkine Media

Too much anaesthesia leads to post-operative complications, longer hospital stays and severe conditions like PTSD. It is estimated that 37-46% of surgical patients are affected by postoperative Delirium (a serious disturbance in mental abilities). In...

 SUDA Pharmaceuticals Reformulating Billion-Dollar Drugs for Oral Delivery

SUDA Pharmaceuticals Reformulating Billion-Dollar Drugs for Oral Delivery

August 30, 2019 12:58 PM AEST| By Team Kalkine Media

Australia?s leading oro-mucosal drug delivery company, SUDA Pharmaceuticals Ltd (ASX: SUD) produces reliable oral sprays by using its proprietary OroMist? technology to redevelop the ex-blockbuster drugs. SUDA?s low-risk oral sprays possess the abili...

 Catch Up On Five Healthcare Stocks- NAN, PME, HLS, MSB, CTE

Catch Up On Five Healthcare Stocks- NAN, PME, HLS, MSB, CTE

August 28, 2019 05:13 PM AEST| By Team Kalkine Media

As per Australia?s Budget for 2019-20, the total Commonwealth health spending is likely to grow from $81.8 billion in 2019-20 to $89.5 billion in 2022-23. This bright outlook cements that fact that the Australian healthcare sector is one of the best...

 Zooming Lens on Neuren’s Drug Candidate, NNZ-2591

Zooming Lens on Neuren’s Drug Candidate, NNZ-2591

August 27, 2019 01:10 PM AEST| By Team Kalkine Media

Australian-headquartered biopharmaceutical company, Neuren Pharmaceuticals Limited (ASX: NEU) develops a range of novel therapies for treating neurodevelopmental disorders with a high unmet medical need, using artificial analogs of neurotrophic pepti...

 ResApp Health Acquires CE Mark Certification For World’s First Smartphone-Based Tool For Acute Respiratory Disease

ResApp Health Acquires CE Mark Certification For World’s First Smartphone-Based Tool For Acute Respiratory Disease

August 26, 2019 10:02 PM AEST| By Team Kalkine Media

ResApp Health Limited (ASX: RAP), is a prime healthcare company headquartered in Brisbane, Australia that creates clinically validated, regulatory-cleared, smartphone applications based digital tools to diagnose and manage acute respiratory diseases....

 What’s brewing up in Pharmaceutical space: MYX, MXC, CGB, OSL

What’s brewing up in Pharmaceutical space: MYX, MXC, CGB, OSL

August 26, 2019 06:57 PM AEST| By Team Kalkine Media

During the ongoing Earnings season, few pharma companies have reported decent sets of numbers, while most of the companies have posted quarterly loss added by higher R&D costs and higher capital expenditure due to establishment of new facilities....

 Noxopharm pre-clinical evidence confirms Veyonda® abscopal effect; NOX completes three years on ASX

Noxopharm pre-clinical evidence confirms Veyonda® abscopal effect; NOX completes three years on ASX

August 26, 2019 02:37 PM AEST| By Team Kalkine Media

On 21 August 2019, clinical-stage drug development company Noxopharm Limited (ASX: NOX) pre-clinical evidence confirmed that its lead drug candidate Veyonda® has the potential to produce off-target responses known as an abscopal effect. The comp...

 Is Healthcare Sector Getting Hot – HLS, NAN, SNZ, PME

Is Healthcare Sector Getting Hot – HLS, NAN, SNZ, PME

August 24, 2019 08:15 AM AEST| By Team Kalkine Media

Despite being one of the best healthcare systems in the world, Australia?s Healthcare sector has been victim to a number of challenges including rising chronic diseases, increasing demand of new treatments, more hospital beds and the ageing populatio...

 New Generation Healthcare Stocks To Look For- RAC, BOT, AVE, JHL, GLH, LSH

New Generation Healthcare Stocks To Look For- RAC, BOT, AVE, JHL, GLH, LSH

August 21, 2019 09:40 PM AEST| By Team Kalkine Media

Digital healthcare service has evolved as one of the fastest-growing industries in the modern era. Introduction of technology in medical science has emerged as one of the biggest blessings for human. Digitally connected network systems have helped me...

 SUDA Makes Speedy Progress with its Robust Product Pipeline

SUDA Makes Speedy Progress with its Robust Product Pipeline

August 21, 2019 01:28 PM AEST| By Team Kalkine Media

SUDA Pharmaceuticals Ltd (ASX: SUD) is transforming the drug delivery technology to improve the lifestyle and health of the global community by offering innovative and high-quality oro-mucosal spray pharmaceutical products to aid in the treatment of...

 A Deep Dive into Imugene’s Opportunities in the Immuno-oncology Market

A Deep Dive into Imugene’s Opportunities in the Immuno-oncology Market

August 20, 2019 04:36 PM AEST| By Team Kalkine Media

Imugene Limited (ASX: IMU) is a clinical stage biotechnology company that focuses on the development of immunotherapies that have the potential to enable a patient?s immune system to recognise and destroy cancer cells. The company is focused on targe...

 A Lens On Noxopharm’s June 2019 Quarterly Results

A Lens On Noxopharm’s June 2019 Quarterly Results

August 19, 2019 03:16 PM AEST| By Team Kalkine Media

Noxopharm Limited (ASX: NOX) has recently released its quarterly report for the three months ended 30 June 2019, covering updates from both Noxopharm and its majority-owned subsidiary, Nyrada Inc. Let us travel through the chief developments of the...

AU_advertise

Advertise your brand on Kalkine Media

Recent Articles






Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.